DotBio

Recent Finacing

Pre-Series A

Recent Raise

$5.6M

DotBio develops intracellular and multi-functional antibody therapies for immuno-oncology using a modular DotBody platform with CoFi/Hot-CoFi stabilization, high-throughput miniaturized assays, and data analytics.